Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00667342 · BASELINE

Baseline characteristics

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma · Source last updated 2023-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      31
    2. group Id
      BG001
      value
      0
    3. group Id
      BG002
      value
      12
    4. group Id
      BG003
      value
      43
    units
    Participants
groups
  1. description
    Stratum A participants had primary tumors potentially resectable by aggressive surgery, such as limb-salvage surgery or amputation, and no evidence of metastasis.
    id
    BG000
    title
    A: Localized Resectable Disease
  2. description
    Participants with localized unresectable primary tumors were to participate in Stratum B. No participants were enrolled to this stratum.
    id
    BG001
    title
    B: Localized Unresectable Disease
  3. description
    Stratum C participants had metastatic tumors.
    id
    BG002
    title
    C: Metastatic Tumors
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          3.5
          value
          12.7
        2. group Id
          BG002
          spread
          4.2
          value
          13.3
        3. group Id
          BG003
          spread
          3.6
          value
          12.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          6
          upper Limit
          20
          value
          12
        2. group Id
          BG002
          lower Limit
          8
          upper Limit
          20
          value
          12
        3. group Id
          BG003
          lower Limit
          6
          upper Limit
          20
          value
          12
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        2. group Id
          BG002
          value
          5
        3. group Id
          BG003
          value
          20
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          16
        2. group Id
          BG002
          value
          7
        3. group Id
          BG003
          value
          23
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Participants were eligible if they were ≤30 years of age on date of diagnostic biopsy confirmation of high-grade osteosarcoma or malignant fibrous histiocytoma (MFH) of bone. Participants had no previous chemotherapy or radiation therapy.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      31
    2. group Id
      BG001
      value
      0
    3. group Id
      BG002
      value
      12
    4. group Id
      BG003
      value
      43
    units
    Participants
groups
  1. description
    Stratum A participants had primary tumors potentially resectable by aggressive surgery, such as limb-salvage surgery or amputation, and no evidence of metastasis.
    id
    BG000
    title
    A: Localized Resectable Disease
  2. description
    Participants with localized unresectable primary tumors were to participate in Stratum B. No participants were enrolled to this stratum.
    id
    BG001
    title
    B: Localized Unresectable Disease
  3. description
    Stratum C participants had metastatic tumors.
    id
    BG002
    title
    C: Metastatic Tumors
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          3.5
          value
          12.7
        2. group Id
          BG002
          spread
          4.2
          value
          13.3
        3. group Id
          BG003
          spread
          3.6
          value
          12.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          6
          upper Limit
          20
          value
          12
        2. group Id
          BG002
          lower Limit
          8
          upper Limit
          20
          value
          12
        3. group Id
          BG003
          lower Limit
          6
          upper Limit
          20
          value
          12
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        2. group Id
          BG002
          value
          5
        3. group Id
          BG003
          value
          20
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          16
        2. group Id
          BG002
          value
          7
        3. group Id
          BG003
          value
          23
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Participants were eligible if they were ≤30 years of age on date of diagnostic biopsy confirmation of high-grade osteosarcoma or malignant fibrous histiocytoma (MFH) of bone. Participants had no previous chemotherapy or radiation therapy.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice